Citations

Showing 10 of 108119 citations.

Temporary balloon occlusion of atrial septal defects in suspected or documented left ventricular diastolic dysfunction: Hemodynamic and clinical findings
Miranda, William R. , Hagler, Donald J. , Reeder, Guy S., Warnes, Carole A. , Connolly, Heidi M. , Egbe, Alexander C. , Taggart, Nathaniel W. , Taggart, Nathaniel W

Mayo Clinic

Catheterization and Cardiovascular Interventions | February 12, 2019 | Volume: 93 | Issue: 6 | Pages: 1069-1075

10.1002/ccd.28150 | PMID 30747481 Get It

AbstractObjectiveTo review our experience with balloon testing prior to atrial septal defect (ASD) closure in adults with left ventricular (LV) diastolic dysfunction.BackgroundASD closure in patients with LV diastolic dysfunction may precipitate LV failure. Temporary ASD occlusion has been used in this scenario but data are limited.MethodsRetrospective review of 27 patients age ≥ 50 years undergoing temporary ASD balloon occlusion between 2000 and 2018 for suspected LV diastolic dysfunction or elevated LV end‐diastolic pressure (LVEDP).ResultsMedian age was 72 years (IQR 66.7; 75.2). Atrial fibrillation was seen in 58% of patients, hypertension in 58%, and coronary artery disease in 26%; 52% were females. Median ASD size was 13 mm (10; 18) and Qp/Qs 1.8 (1.6; 2.2). Median LVEDP was 14 mmHg (12; 22); pulmonary artery wedge pressure (PAWP) 12 mmHg (9; 16.5) and left atrial pressure (LAP) 13.5 mmHg (8; 16.3). After a median of 5 min (3; 10) of balloon occlusion, patients with baseline LVEDP ≥15 mmHg had more significant increases in LVEDP (9 [6; 12] vs. 2 mmHg [0.5; 5]; p = 0.03) and LAP/PAWP (10.5 [8.3; 16.3] vs. 1.5 mmHg [−1.5; 3]; p = 0.0003) than those with baseline LVEDP <15 mmHg. None of those with a baseline LVEDP <15 mmHg had a LAP/PAWP >15 mmHg during balloon testing compared to 92% of patients with a baseline LVEDP ≥15 mmHg.ConclusionLVEDP might be used to predict LAP post‐ASD closure. Comorbidities typically associated with LV diastolic dysfunction are common in these patients and should be considered in their management.
Time-driven activity-based cost analysis for outpatient anticoagulation therapy: direct costs in a primary care setting with optimal performance
Bobade, Rohit A., Helmers, Richard A. , Jaeger, Thomas M. , Odell, Laura J., Haas, Derek A. , Kaplan, Robert S.

Mayo Clinic

Journal of Medical Economics | February 12, 2019 | Volume: 22 | Issue: 5 | Pages: 471-477

10.1080/13696998.2019.1582058 | PMID 30744455 Get It

Outcomes of sinonasal inverted papilloma resection by surgical approach: an updated systematic review and meta‐analysis
Peng, Rui, Thamboo, Andrew , Zhou, Bing , Hwang, Peter H. , Hwang, Peter H , Peng, Rui, Choby, Garret , Ma, Yifei

Mayo Clinic

International Forum of Allergy & Rhinology | February 12, 2019 | Volume: 9 | Issue: 6 | Pages: 573-581

10.1002/alr.22305 | PMID 30748098 Get It

Background Selecting the optimal surgical approach for resection of sinonasal inverted papilloma (SIP) remains a challenge, with endoscopic, external, and combined approaches being utilized. This systematic review was conducted as an update to a 2006 systematic review to determine the preferred surgical approach for tumor control. Methods The study protocol was developed a priori following the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) process. Data were collected and outcomes were analyzed according to surgical approach and sites of tumor involvement. Results A total of 96 papers and 4134 SIP patients were included. The overall recurrence rate was 12.80% (322/2515) for the endoscopic approach group, 16.58% (182/1098) for the external approach group, and 12.60% (65/516) for the combined approach group. Meta‐analysis by random effects model showed that the summarized risk ratio (RR) of recurrence was 0.61 (95% confidence interval [CI], 0.44 to 0.85, p = 0.003), I 2 = 37.95% for the endoscopic vs external approach; 0.98 (95% CI, 0.69 to 1.39, p = 0.901), I 2 = 9.06% for the endoscopic vs combined approach; 1.61 (95% CI, 1.06 to 2.43, p = 0.025), I 2 = 0.00% for the external vs combined approach. After adjusting for publication bias, the adjusted RRs were 0.66 ( p = 0.014) for endoscopic vs external; 0.99 ( p = 0.955) for endoscopic vs combined; and 1.33 ( p = 0.224) for external vs combined. Conclusion An enlarging and maturing body of literature continues to indicate that endoscopic approaches result in significantly lower recurrence rates than open approaches for surgical resection of SIP.
We Need to Educate Young Lung Cancer Patients About Menopause Risk
Faruqi, Fahad, Ruddy, Kathryn J. , Cathcart-Rake, Elizabeth

Mayo Clinic

Lung Cancer Management | February 12, 2019 | Volume: 8 | Issue: 1 | Pages: No page available

10.2217/lmt-2018-0018 | PMID 31044017 Get It

Mitochondrial Morphology, Dynamics, and Function in Human Pressure Overload or Ischemic Heart Disease With Preserved or Reduced Ejection Fraction
Chaanine, Antoine H. , Joyce, Lyle D., Stulak, John M., Maltais, Simon, Joyce, David L. , Klaus, Katherine A. , Hajjar, Roger J. , Redfield, Margaret M. , Klaus, Katherine, Dearani, Joseph A. , Nair, K. Sreekumaran

Mayo Clinic

Circulation: Heart Failure | February 12, 2019 | Volume: 12 | Issue: 2 | Pages: No page available

10.1161/circheartfailure.118.005131 | PMID 30744415 Get It

Background: The FOXO3a (forkhead box O3a)-BNIP3 (B-cell lymphoma 2/adenovirus E1B 19kDa interacting protein 3) pathway modulates mitochondrial dynamics and function and contributes to myocardial remodeling in rodent models of heart failure. We sought to investigate the expression of this pathway along with the expression of mitochondrial biogenesis (PGC-1α [peroxisome proliferator-activated receptor-γ coactivator-1α]), dynamics (DRP-1 [dynamin-related protein 1], OPA-1 [optic atrophy 1], and MFN 2 [mitofusin 2]), and oxidative phosphorylation (citrate synthase and electron transport chain complexes) markers and COX IV (cytochrome C oxidase) activity in myocardium from patients with valvular or ischemic heart disease and heart failure with preserved ejection fraction (HFpEF) or heart failure with reduced ejection fraction (HFrEF). Methods and Results: Subepicardial left ventricular biopsies (10×1×1 mm 3 ) were obtained at aortic valve replacement (HFpEF AVR , n=5; and HFrEF AVR , n=4), coronary artery bypass grafting (HFpEF CABG , n=5; and HFrEF CABG , n=5), or left ventricular assist device implantation (HFrEF LVAD , n=4). Subepicardial biopsies from patients with normal left ventricular function (n=2) and from donor hearts (n=3) served as controls (normal). Relative to normal, mitochondrial fragmentation and cristae destruction were evident, and mitochondrial area was decreased in HFpEF; 1.00±0.09 versus 0.71±0.08; P =0.016. These mitochondrial morphological changes were more pronounced in HFrEF (0.54±0.06); P =0.002 HFpEF versus HFrEF. BNIP3 (monomer+dimer) expression was increased in HFpEF (3.99±2.44) and in HFrEF (5.19±1.70) relative to normal; P =0.004 and P <0.001, respectively. However, BNIP3 monomer was increased in HFrEF (4.32±1.43) compared with normal (0.99±0.06) and HFpEF (1.97±0.90); P =0.001 and 0.004, respectively. The HFrEF group uniquely showed increase in DRP-1 expression (1.94±0.38) and decreases in PGC-1α expression (0.61±0.07) and COX IV activity (0.70±0.10) relative to normal; P =0.013, P <0.001, and P <0.001, respectively, with no significant change in electron transport chain complexes expression. Conclusions: These findings in human myocardium confirm studies in rodents where contractile dysfunction is associated with activation of the FOXO3a-BNIP3 pathway and altered mitochondrial dynamics, biogenesis, and function.
Is It Appropriate to Place Subcutaneous Chest Ports in Patients with Neutropenia?
Johnson, Evan J. , Johnson, Evan J.

Mayo Clinic

Radiology | February 12, 2019 | Volume: 291 | Issue: 2 | Pages: 519-520

10.1148/radiol.2019190095 | PMID 30776249 Get It

Investigating Asthma, Allergic Disease, Passive Smoke Exposure, and Risk of Rheumatoid Arthritis
Kronzer, Vanessa L. , Crowson, Cynthia S. , Sparks, Jeffrey A. , Vassallo, Robert , Davis, John M. , Vassallo, Robert , Sparks, Jeffrey A , Kronzer, Vanessa L , Davis, John M

Mayo Clinic

Arthritis & Rheumatology | February 12, 2019 | Volume: 71 | Issue: 8 | Pages: 1217-1224

10.1002/art.40858 | PMID 30747496 Get It

ObjectiveRheumatoid arthritis (RA) is postulated to originate at mucosal surfaces, particularly the airway mucosa. To investigate this hypothesis, we determined the association between RA and asthma, passive smoke exposure, and age at start of smoking.MethodsFor this case–control study, we identified 1,023 cases of RA (175 incident) within a single‐center biobank population, using a rules‐based algorithm that combined self‐report with 2 diagnostic codes. Exposures were self‐reported on biobank questionnaires. Logistic regression models were used to calculate the association of exposures with RA, adjusting for potential confounders. Odds ratios (ORs) with 95% confidence intervals (95% CIs) were calculated.ResultsAfter adjustment for allergies, urban environment, and passive smoke exposure, asthma was found to be associated with RA in the full cohort (OR 1.28 [95% CI 1.04–1.58; P = 0.02]) but not the incident RA cohort (OR 1.17 [95% CI 0.66–2.06; P = 0.60]). History of allergic disease was associated with RA in both the full cohort (OR 1.30 [95% CI 1.12–1.51; P < 0.001]) and the incident RA cohort (OR 1.61 [95% CI 1.11–2.33; P = 0.01]), especially food allergy, which was significantly associated with RA in the full cohort (OR 1.38 [95% CI 1.08–1.75; P = 0.01]) and showed a trend toward significance in the incident RA cohort (OR 1.83 [95% CI 0.97–3.45; P = 0.06]). Passive smoke exposure at home or work was not associated with RA. Finally, age at start of smoking was not associated with increased odds of developing RA in either the full cohort (OR 1.03 [95% CI 1.00–1.06; P = 0.03]) or the incident RA cohort (OR 1.00 [95% CI 0.92–1.08; P = 0.98]).ConclusionAsthma and allergies may be associated with increased risk of RA. Passive smoke exposure and early age at start of smoking do not appear to influence risk of RA.
Value of board certification in a pharmacy specialty
Hung, Joseph C.

Mayo Clinic

American Journal of Health-System Pharmacy | February 12, 2019 | Volume: 52 | Issue: 12 | Pages: 1349-1349

10.1093/ajhp/52.12.1349 | PMID 7656128 Get It

Hydrogels: Multifunctional “Hydrogel Skins” on Diverse Polymers with Arbitrary Shapes (Adv. Mater. 7/2019)
Yu, Yan , Yuk, Hyunwoo , Parada, German Alberto , Wu, You , Liu, Xinyue , Nabzdyk, Christoph S. , Youcef‐Toumi, Kamal , Zang, Jianfeng , Zhao, Xuanhe

Mayo Clinic

Advanced Materials | February 12, 2019 | Volume: 31 | Issue: 7 | Pages: No page available

10.1002/adma.201970044 Get It

Year in Review in Cardiac Electrophysiology
Hussein, Ayman A. , Madhavan, Malini , Viswanathan, Mohan , Ceresnak, Scott R. , Park, David , Wang, Paul J. , Park, David S , Tzou, Wendy S. , Steinberg, Benjamin A. , Davis, Darryl Raymond , Kapa, Suraj

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | February 12, 2019 | Volume: 12 | Issue: 2 | Pages: No page available

10.1161/circep.118.007142 | PMID 30744401 Get It